Sandy Balkin

Sandy joined Royalty Pharma in 2021. He is responsible for building and managing a cross-functional team charged with leveraging data to identify and support investment opportunities. Prior to joining Royalty Pharma, Sandy was Managing Director and Leader of the Truist Securities’ Data Science and Engineering research team developing capabilities in data science, machine learning and alternative data and integrating them into quantamental investment research. Over his career, he has built and led advanced business analytics functions at top pharmaceutical companies including Pfizer, Boehringer Ingelheim, and Sanofi.